<?xml version="1.0" encoding="UTF-8"?>
<p>More recently, an extension of the previous French study was published, which suggested an efficacy of HCHQ.(
 <xref rid="R26" ref-type="bibr">26</xref>) In this study, a rapid fall of nasopharyngeal viral load tested by polymerase chain reaction was noted, with 83% negative at Day 7, 93% at Day 8, and virus cultures from respiratory samples were negative in 97.5% at Day 5. There were numerous problems with this study, the most important of which was a lack of outcome data and some confusion as to patient numbers with some dropping out and others only just starting therapy after the 6-day period ended. In a journal pre-proof, another group of French investigators repeated the study in 10 patients and 80% were still positive for SARS-CoV-2 RNA at Days 5â€“6 after treatment initiation.(
 <xref rid="R27" ref-type="bibr">27</xref>) Finally, in a Chinese pilot study of 30 patients, 15 received CHQ, 13 tested negative for SARS CoV-2 after a week of treatment vs 14 of the controls.(
 <xref rid="R28" ref-type="bibr">28</xref>)
</p>
